Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Pediatric Patients (Ages 6 to 14 Years) With Acute Asthma
Brief Summary: This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.


Options:
A: Intervention Type: DRUG; Name: inhaled corticosteroids; Assigned to Arm(s): N/A
B: Arm Label: Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: montelukast (MON), Drug: placebo nasal, Drug: ADVAIR DISKUS | Arm Label: Fluticasone Propionate/Salmeterol (FSC); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: placebo nasal, Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: fluticasone propionate (FP), Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Montelukast (MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast (MON), Drug: placebo nasal, Drug: placebo DISKUS | Intervention Type: DRUG; Name: fluticasone propionate/salmeterol (FSC); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: montelukast (MON); Assigned to Arm(s): Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: fluticasone propionate (FP); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS) | Intervention Type: DRUG; Name: placebo nasal; Assigned to Arm(s): Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: ADVAIR DISKUS; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: placebo capsule; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC) | Intervention Type: DRUG; Name: placebo DISKUS; Assigned to Arm(s): Montelukast (MON)
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: placebo (unspecified) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast sodium | Intervention Type: DRUG; Name: montelukast sodium; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Comparator: placebo (unspecified); Assigned to Arm(s): 1
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: montelukast | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: Placebo | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Comparator: Placebo; Assigned to Arm(s): 2

Answer: C